Literature DB >> 18603330

Explorations into modeling human oral bioavailability.

Zhi Wang1, Aixia Yan, Qipeng Yuan, Johann Gasteiger.   

Abstract

Explorations into modeling human oral bioavailability started with a whole dataset of 772 drug compounds. First, training set and test set were chosen based on Kohonen's self-organizing Neural Network (KohNN). Then, a quantitative model of the whole dataset was built using multiple linear regression (MLR) analysis. This model had limited predictability emphasizing that a variety of pharmacokinetic factors influence human oral bioavailability. In order to explore whether better models can be built when the compounds share some ADME properties, four subsets were chosen from the whole dataset to build quantitative models and better models were obtained by MLR analysis. These studies show that, indeed, good models for predicting human oral bioavailability can be obtained from datasets sharing certain pharmacokinetic properties.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603330     DOI: 10.1016/j.ejmech.2008.05.017

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Discriminating of HMG-CoA reductase inhibitors and decoys using self-organizing maps.

Authors:  Zhi Wang; Aixia Yan
Journal:  Mol Divers       Date:  2010-11-12       Impact factor: 2.943

Review 2.  The role of transporters in the pharmacokinetics of orally administered drugs.

Authors:  Sarah Shugarts; Leslie Z Benet
Journal:  Pharm Res       Date:  2009-06-30       Impact factor: 4.200

Review 3.  Advances in computationally modeling human oral bioavailability.

Authors:  Junmei Wang; Tingjun Hou
Journal:  Adv Drug Deliv Rev       Date:  2015-01-09       Impact factor: 15.470

4.  A novel chemometric method for the prediction of human oral bioavailability.

Authors:  Xue Xu; Wuxia Zhang; Chao Huang; Yan Li; Hua Yu; Yonghua Wang; Jinyou Duan; Yang Ling
Journal:  Int J Mol Sci       Date:  2012-06-07       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.